$48.15
+2.47%
N/A+$1.16
Healthcare
Biotechnology
NASDAQ
Active Trading
CRISPR Therapeutics AG (CRSP) is a biotechnology firm dedicated to pioneering gene-based medicines for severe diseases. The company achieves this through its ...
Financial highlights
Latest / TTM · 6 periods
Snapshot
Latest / TTM: 2026-07-22
Gross Margin
—
Net Margin
—
P/E Ratio
—
Debt / Equity
—
Profitability
Profitability table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Gross MarginGross profit as a percentage of revenue. | 88.9% | -25186.7% | 64.8% | -215.0% | -6537.0% | — |
| Operating MarginOperating income as a percentage of revenue. | 40.9% | -154394.7% | -60.1% | -1333.0% | -16191.4% | — |
| Net MarginNet income as a percentage of revenue. | 41.4% | -149122.7% | -41.5% | -1046.4% | -16569.8% | — |
| EBITDA MarginEBITDA divided by revenue. | 43.5% | -143653.2% | -35.4% | -981.2% | -15911.3% | — |
| Pre-tax MarginPre-tax profit as a percentage of revenue. | 41.6% | -149197.2% | -40.7% | -1036.2% | -16466.2% | — |
Liquidity & leverage
Liquidity & leverage table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Current RatioCurrent assets divided by current liabilities. | 20.17 | 15.30 | 17.54 | 22.07 | 13.32 | — |
| Quick RatioLiquid assets divided by current liabilities. | 20.17 | 15.30 | 17.54 | 22.07 | 13.32 | — |
| Cash RatioCash and equivalents divided by current liabilities. | 7.70 | 1.75 | 3.58 | 3.40 | 2.38 | — |
| Debt / AssetsDebt as a share of total assets. | 8.2% | 10.9% | 10.7% | 10.0% | 17.4% | — |
| Debt / EquityDebt compared with shareholder equity. | 0.09 | 0.13 | 0.13 | 0.12 | 0.21 | — |
Operating efficiency
Operating efficiency table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Receivables TurnoverHow often receivables are collected in a year. | 2993.71x | 0.00x | 1.85x | 1.40x | 0.00x | — |
| Inventory TurnoverHow often inventory is sold in a year. | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | — |
| Payables TurnoverHow often payables are paid in a year. | 6.83x | 4.02x | 3.41x | 7.50x | 20.92x | — |
| Asset TurnoverRevenue generated per dollar of assets. | 0.33x | 0.00x | 0.17x | 0.02x | 0.00x | — |
| Working Capital TurnoverRevenue generated per dollar of working capital. | 0.47x | 0.00x | 0.21x | 0.02x | 0.00x | — |
Valuation ratios
Valuation ratios table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| P/E RatioPrice paid for each dollar of earnings. | 15.25x | -4.86x | -32.27x | -9.07x | -8.11x | — |
| P/B RatioPrice paid for each dollar of book value. | 2.40x | 1.69x | 2.63x | 1.72x | 2.45x | — |
| P/S RatioPrice paid for each dollar of sales. | 6.30x | 7248.62x | 13.40x | 94.87x | 1343.50x | — |
| P/FCF RatioPrice paid for each dollar of free cash flow. | 12.59x | -5.93x | -18.38x | -22.95x | -13.63x | — |
| Dividend YieldAnnual dividend divided by current share price. | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |